Search research articles
Contact Us
Filters
Showing results (11-20 of 198) with videos related to
Page
of 20
Sort By:
Immunotherapy
|
January 28, 2017
Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy
Alvaro Moreira, Waltraud Leisgang, Gerold Schuler, et al.
Cancers
|
January 13, 2021
Current Melanoma Treatments: Where Do We Stand?
Alvaro Moreira, Lucie Heinzerling, Nina Bhardwaj, et al.
Anticancer Research
|
September 4, 2020
ALK Inhibitors Do Not Increase Sensitivity to Radiation in EML4-ALK Non-small Cell Lung Cancer
Kathrin Fleschutz, Lisa Walter, Rumo Leistner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 9, 2016
Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanoma
Michael C Kirchberger, Axel Hauschild, Gerold Schuler, et al.
European Journal of Dermatology : EJD
|
March 2, 2002
Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient
Lucie Heinzerling, Reinhard Dummer, Günter Burg, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
May 12, 2006
Sublingual immunotherapy
Lucie Heinzerling, Margitta Worm, Karl-Christian Bergmann, et al.
Journal of the American Academy of Dermatology
|
August 31, 2024
Clinical and pathological characterization of tebentafusp-associated skin toxicity: A cohort study with 33 patients
Dirk Tomsitz, Katrin Kerl, Lars Einar French, et al.
Photodermatology, Photoimmunology & Photomedicine
|
March 12, 2019
Characterization of tanning behavior assessed via online survey: Attitudes, habits, and preventive measures with focus on sunscreen use
Constanze K Schneiderbanger, Gerold Schuler, Lucie Heinzerling, et al.
Journal of Cancer Research and Clinical Oncology
|
September 8, 2019
C-reactive protein as an early marker of immune-related adverse events
Amir-Reza Abolhassani, Gerold Schuler, Michael Constantin Kirchberger, et al.
The American Journal of Medicine
|
April 17, 2014
Drug-induced dilemma: angiokeratomas and decreased renal function
Stefan Schliep, Franklin Kiesewetter, Miklos Simon, et al.
Page
of 20
Search research articles
Search
Showing results (11-20 of 198) with videos related to
Sort By:
Page
of 20
Immunotherapy
|
January 28, 2017
Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy
Alvaro Moreira, Waltraud Leisgang, Gerold Schuler, et al.
Cancers
|
January 13, 2021
Current Melanoma Treatments: Where Do We Stand?
Alvaro Moreira, Lucie Heinzerling, Nina Bhardwaj, et al.
Anticancer Research
|
September 4, 2020
ALK Inhibitors Do Not Increase Sensitivity to Radiation in EML4-ALK Non-small Cell Lung Cancer
Kathrin Fleschutz, Lisa Walter, Rumo Leistner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 9, 2016
Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanoma
Michael C Kirchberger, Axel Hauschild, Gerold Schuler, et al.
European Journal of Dermatology : EJD
|
March 2, 2002
Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient
Lucie Heinzerling, Reinhard Dummer, Günter Burg, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
May 12, 2006
Sublingual immunotherapy
Lucie Heinzerling, Margitta Worm, Karl-Christian Bergmann, et al.
Journal of the American Academy of Dermatology
|
August 31, 2024
Clinical and pathological characterization of tebentafusp-associated skin toxicity: A cohort study with 33 patients
Dirk Tomsitz, Katrin Kerl, Lars Einar French, et al.
Photodermatology, Photoimmunology & Photomedicine
|
March 12, 2019
Characterization of tanning behavior assessed via online survey: Attitudes, habits, and preventive measures with focus on sunscreen use
Constanze K Schneiderbanger, Gerold Schuler, Lucie Heinzerling, et al.
Journal of Cancer Research and Clinical Oncology
|
September 8, 2019
C-reactive protein as an early marker of immune-related adverse events
Amir-Reza Abolhassani, Gerold Schuler, Michael Constantin Kirchberger, et al.
The American Journal of Medicine
|
April 17, 2014
Drug-induced dilemma: angiokeratomas and decreased renal function
Stefan Schliep, Franklin Kiesewetter, Miklos Simon, et al.
Page
of 20